• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.

作者信息

Bishop J E, Collins E D, Okamura W H, Norman A W

机构信息

Department of Biochemistry, University of California, Riverside.

出版信息

J Bone Miner Res. 1994 Aug;9(8):1277-88. doi: 10.1002/jbmr.5650090818.

DOI:10.1002/jbmr.5650090818
PMID:7976510
Abstract

The profile of structural preference for the ligand binding domain of the human vitamin D binding protein (DBP) was determined by steroid competition assay of 71 analogs of 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3]. The following categories of structural modification were evaluated [values represent fold change; R = reduction, I = increase in binding to the DBP from the reference 1 alpha, 25(OH)2D3]: (1) deletion in the A ring of the 1 alpha-hydroxyl-(20-1600I); (2) conversion of the triene system to the previtamin form (6-40R); (3) addition of substituents to carbon 11 of the C ring (4-14R); (4) inversion of the C/D ring junction (8-20R); (5) unsaturation of the D ring (16-ene; 4-140R); (6) replacement of hydrogen with deuterium atoms (no effect); alteration of the side chain by (7) adding or deleting carbon atoms (5-12R); (8) addition of fluorines (0.2-10R); (9) presence of unsaturation (22-ene, 0-5R; 23-ene, 3R-10I; 23-yne, 5-20R); (10) addition of hydroxyls (2-100R); and (11) addition of an aromatic ring (0-20I). Thus the DBP ligand binding domain could tolerate only modest changes to the structure of 1 alpha,25(OH)2D3 without a reduction in binding of the analog. The increases in binding seen in the aromatic side chain and with a triple bond at carbon-23 may be indicative of a preferred conformation of the flexible 1 alpha, 25(OH)2D3 side chain. In addition, a comparison was made of the DBP ligand binding domain with that of the human HL-60 cell 1 alpha, 25(OH)2D3 nuclear receptor. Both ligand binding domains could equivalently accommodate to the presence of (1) a side-chain cyclopropyl group, (2) 22-ene or 23-yne, (3) lengthening the side chain by two carbons, (4) presence of four to six fluorine atoms, (5) substitution of an oxygen for carbon 22, and (6) presence of a 22-[m-(dimethylhydroxymethyl)phenyl] aromatic group in the side chain. The DPB could tolerate better than the HL-60 cell receptor the presence of a 22-(p-hydroxyphenyl) aromatic group in the side chain and the absence of the 1 alpha-hydroxyl. In contrast, the HL-60 cell receptor could tolerate better than the DBP the following structural modifications: presence of a 16-ene, or 16-ene plus 23-yne unsaturation, and presence of an 11 beta-hydroxyl.

摘要

相似文献

1
Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.
J Bone Miner Res. 1994 Aug;9(8):1277-88. doi: 10.1002/jbmr.5650090818.
2
1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.1α,25 - 二羟基 - 16 - 烯 - 23 - 炔 - 维生素D3和1α,25 - 二羟基 - 16 - 烯 - 23 - 炔 - 20 - 表 - 维生素D3:1α,25 - 二羟基维生素D3的类似物,它们通过C - 24氧化途径抵抗代谢,而是通过C - 3差向异构化途径代谢。
Arch Biochem Biophys. 2000 Nov 15;383(2):197-205. doi: 10.1006/abbi.2000.2074.
3
Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.靶器官(肠道、肾脏和骨骼)对1,25 - 二羟维生素D3及其两种类似物的选择性生物学反应。
Cancer Res. 1993 Sep 1;53(17):3935-42.
4
Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.维生素D结合蛋白配体结合口袋内配体及配体模拟物的结构与取向的作用
Biochemistry. 1997 Jun 17;36(24):7432-6. doi: 10.1021/bi962730i.
5
Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.对维生素D结合蛋白亲和力低的维生素D类似物:体外活性增强而体内活性降低。
J Bone Miner Res. 1991 Oct;6(10):1051-7. doi: 10.1002/jbmr.5650061006.
6
Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.1α,25-二羟基维生素D3类似物的结构-功能研究:对白血病细胞生长、分化及肠道钙吸收的不同影响
Cancer Res. 1990 Nov 1;50(21):6857-64.
7
Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.CD环修饰的1α,25-二羟基维生素D类似物的生物活性:C环和五元D环类似物。
J Bone Miner Res. 2000 Feb;15(2):237-52. doi: 10.1359/jbmr.2000.15.2.237.
8
1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia).1,25-二羟基维生素D3类似物对肠道钙快速吸收(快速钙转运)的结构-功能评估
J Bone Miner Res. 1992 Apr;7(4):457-63. doi: 10.1002/jbmr.5650070414.
9
Conformationally restricted analogs of 1 alpha, 25-dihydroxyvitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor.1α,25 - 二羟基维生素D3及其20 - 差向异构体的构象受限类似物:用于研究维生素D与受体结合的三维结构的化合物。
J Med Chem. 1996 Jul 5;39(14):2727-37. doi: 10.1021/jm9600048.
10
Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.二羟基化19-去甲(前)维生素D3的生物活性
J Bone Miner Res. 1993 Aug;8(8):1009-15. doi: 10.1002/jbmr.5650080815.

引用本文的文献

1
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.延长释放型钙三醇可有效提高超重非透析慢性肾脏病伴继发性甲状旁腺功能亢进患者血清总 25-羟维生素 D 水平。
Am J Nephrol. 2022;53(6):446-454. doi: 10.1159/000524289. Epub 2022 May 12.
2
Diagnostic Aspects of Vitamin D: Clinical Utility of Vitamin D Metabolite Profiling.维生素D的诊断要点:维生素D代谢产物分析的临床应用
JBMR Plus. 2021 Dec 3;5(12):e10581. doi: 10.1002/jbm4.10581. eCollection 2021 Dec.
3
Development of In Vitro and In Vivo Evaluation Systems for Vitamin D Derivatives and Their Application to Drug Discovery.
维生素 D 衍生物的体外和体内评价体系的建立及其在药物发现中的应用。
Int J Mol Sci. 2021 Oct 31;22(21):11839. doi: 10.3390/ijms222111839.
4
Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).合成代谢药物在结直肠肿瘤发生中的作用:神话与现实(综述)。
Oncol Rep. 2019 Dec;42(6):2228-2244. doi: 10.3892/or.2019.7351. Epub 2019 Oct 3.
5
Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.维生素D代谢与信号转导基因的遗传多态性与乳腺癌风险:一项巢式病例对照研究。
PLoS One. 2015 Oct 21;10(10):e0140478. doi: 10.1371/journal.pone.0140478. eCollection 2015.
6
The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.《2013/14药理学简明指南:核激素受体》
Br J Pharmacol. 2013 Dec;170(8):1652-75. doi: 10.1111/bph.12448.
7
Calcitriol imparts neuroprotection in vitro to midbrain dopaminergic neurons by upregulating GDNF expression.骨化三醇通过上调 GDNF 表达在体外赋予中脑多巴胺能神经元神经保护作用。
PLoS One. 2013 Apr 23;8(4):e62040. doi: 10.1371/journal.pone.0062040. Print 2013.
8
Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP).
Endocrine. 1995 Apr;3(4):263-6. doi: 10.1007/BF03021403.
9
Synthesis of 1alpha,25-dihydroxyvitamin D analogues featuring a S(2)-symmetric CD-ring core.具有S(2)-对称CD环核心的1α,25-二羟基维生素D类似物的合成。
Molecules. 2009 Feb 24;14(2):894-903. doi: 10.3390/molecules14020894.
10
Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease.透析前慢性肾脏病患者血清1,25-二羟基维生素D与死亡率的关系
Clin Exp Nephrol. 2008 Apr;12(2):126-131. doi: 10.1007/s10157-007-0023-4. Epub 2008 Jan 9.